Almi Företagspartner - till startsidan
Almi Företagspartner - till startsidan
Sök Meny
Pitcha din startup
English E-tjänster Kontaktcenter

ApoGlyx

New therapeutic concepts for sepsis

  • CEO: Michael Rützler
  • First investment year: 2021
  • Fund: South
  • Business sector: Life Science
ApoGlyx

ApoGlyx

ApoGlyx develops new therapeutic concepts for metabolical and inflammatory diseases, such as sepsis, with innovative and proprietary Aquaporin technology.